With multiple active, patient trials, discover where you can participate in our leading clinical trials.
Become a patient
Our Active Patient Trial Sites
IHL-42X
Obstructive Sleep Apnoea
Clinical Trial Overview
RePOSA study
The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive sleep apnea who are intolerant, non-compliant, or naïve to positive airway pressure. This study is being conducted at sites in the United States and will expand to sites in Europe and the United Kingdom in 2025.
Find your trial site locations
To find your patient trial site listings, click below.
IHL-675A-RA
Rheumatoid Arthritis
Clinical Trial Overview
The goal of this randomised, double-blind, placebo-controlled Phase II clinical trial is to assess the safety and effect of IHL-675A in rheumatoid arthritis patients on pain, and function according to RAPID-3. This study is being conducted at sites in Australia.
Find your trial site locations
To find your patient trial site listings, click below.
Subscribe and stay connected
Stay up to date with Incannex’s leading research and development programs, multiple secondary assets, investor relations and biotechnology advancements.
"*" indicates required fields